ELDN Eledon Pharmaceuticals, Inc. - Common Stock
ELDN Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
ELDN Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
ELDN Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 4 33,3%
- Compra 7 58,3%
- Mantener 1 8,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
5 analistas · 2026-08-19Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.33 | $-0.19 | -0.14% |
| 31 de diciembre de 2025 | $-0.10 | $-0.21 | 0.11% |
| 30 de septiembre de 2025 | $-0.21 | $-0.26 | 0.04% |
| 30 de junio de 2025 | $-0.13 | $-0.23 | 0.10% |
| 31 de marzo de 2025 | $-0.08 | $-0.31 | 0.23% |
| 31 de diciembre de 2024 | $0.67 | $-0.32 | 0.99% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ELDN | $114M | -2.9 | — | — | -69.4% | — |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | — |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | — |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | — |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
| SRZN | — | — | — | — | — | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $66M | $52M | $30M | $27M | $24M | $6M | $8M | $7M | $2M | $3M | $33M | $15M | |
| SG&A Expense | $17M | $19M | $13M | $13M | $13M | $10M | $6M | $7M | $11M | $2M | $13M | $9M | |
| Operating Expenses | $83M | $71M | $43M | $88M | $37M | $18M | $16M | $14M | $13M | $5M | $45M | $23M | |
| Operating Income | · | · | $-43M | $-88M | $-37M | $-18M | $-16M | $-14M | $-13M | $-5M | $-45M | $-23M | |
| Other Non-op | $4M | $4M | $3M | $462.0K | $7.0K | $79.0K | $40.0K | $-5.0K | $5.0K | $-527.0K | · | $166.0K | |
| Pretax Income | $-46M | $-36M | $-117M | $-88M | $-37M | $-23M | $-16M | $-14M | $-13M | $-6M | · | · | |
| Income Tax | $35.0K | $431.0K | $0 | $0 | $-2M | $-404.0K | · | · | · | $0 | $0 | $0 | |
| Net Income | $-46M | $-36M | $-117M | $-88M | $-35M | $-23M | $-16M | $-14M | $-13M | $-6M | $-45M | $-23M | |
| EPS (Basic) | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 | · | · | · | · | · | · | · | |
| Shares (Basic) | 81,836,246 | 48,543,787 | 24,619,197 | 14,285,254 | 14,819,582 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 81,836,246 | 48,543,787 | 24,619,197 | 14,285,254 | 14,819,582 | · | · | · | · | · | · | · | |
| EBITDA | · | · | · | $-88M | $-37M | $-18M | $-16M | · | $-13M | · | $-45M | $-23M |
Balance general 25
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $21M | $5M | $56M | $85M | $114M | $9M | $13M | $17M | $1M | $24M | $105M | |
| Short-term Investments | $111M | $120M | $46M | $0 | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $4M | $5M | $3M | $4M | $1M | $1M | $1M | $2M | $33.0K | $3M | $2M | |
| Other Current Assets | $11.0K | $104.0K | $90.0K | $28.0K | $34.0K | $38.0K | $54.0K | $36.0K | $18.0K | $33.0K | · | · | |
| Current Assets | $136M | $144M | $56M | $60M | $88M | $116M | $10M | $14M | $19M | $1M | $67M | $108M | |
| PP&E (Net) | · | · | · | · | · | · | $5.0K | $14.0K | $25.0K | $31.0K | $489.0K | $33.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | $228.0K | $654.0K | $91.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | $130.0K | $165.0K | $58.0K | |
| Goodwill | · | · | $0 | $0 | $49M | $49M | · | $2M | $2M | · | · | · | |
| Other Non-current Assets | $322.0K | $363.0K | $186.0K | $150.0K | $400.0K | $383.0K | $639.0K | $869.0K | · | $15.0K | $45.0K | · | |
| Total Assets | $169M | $177M | $89M | $93M | $171M | $197M | $11M | $17M | $21M | $1M | $68M | $108M | |
| Accounts Payable | $4M | $6M | $967.0K | $2M | $2M | $1M | $329.0K | $689.0K | $418.0K | $338.0K | $1M | $765.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $113.0K | $5M | $3M | |
| Current Liabilities | $18M | $12M | $4M | $6M | $4M | $2M | $1M | $3M | · | $4M | $6M | $4M | |
| Capital Leases | $283.0K | $640.0K | $0 | $383.0K | $400.0K | · | $144.0K | · | · | · | · | · | |
| Deferred Tax | $2M | $2M | $2M | $2M | $2M | $4M | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $88.0K | · | |
| Total Liabilities | $32M | $59M | $82M | $9M | $7M | $7M | $1M | $3M | $1M | $4M | $6M | $4M | |
| Common Stock | $75.0K | $60.0K | $24.0K | $14.0K | $14.0K | $15.0K | $1.0K | $9.0K | $7.0K | $1.0K | $23.0K | $22.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $190M | |
| Retained Earnings | $-401M | $-356M | $-319M | $-203M | $-115M | $-80M | $-58M | $-42M | $-28M | $-14M | $-131M | $-86M | |
| AOCI | $24.0K | $26.0K | · | · | · | · | · | · | · | $-1.0K | $-55.0K | · | |
| Stockholders' Equity | $81M | $62M | $-48M | $24M | $164M | $191M | $9M | $14M | $19M | $-3M | $3M | $104M | |
| Liabilities + Equity | $169M | $177M | $89M | $93M | $171M | $197M | $11M | $17M | $21M | $1M | $68M | $108M | |
| Shares Outstanding | 75,430,033 | 59,789,275 | 24,213,130 | 13,776,788 | 14,306,788 | 15,160,397 | 720,408 | 9,422,143 | 7,110,414 | 394,306 | 22,597,144 | 22,382,340 |
Flujo de Efectivo 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $5.0K | $9.0K | $11.0K | $22.0K | $35.0K | · | · | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Deferred Tax | $5.0K | $431.0K | · | · | $-2M | $-404.0K | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | $2M | $2M | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-47M | $-40M | $-28M | $-29M | $-15M | $-14M | $-12M | $-15M | $-5M | $-41M | $-21M | |
| CapEx | · | · | · | · | · | · | · | · | · | $9.0K | $565.0K | $25.0K | |
| Investing Cash Flow | $11M | $-70M | $-45M | · | · | $11M | · | · | $23M | · | · | · | |
| Stock Issued | · | · | · | · | · | $9M | $10M | $7M | $5M | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $9M | $10M | · | $5M | · | · | · | |
| Financing Cash Flow | $54M | $134M | $33M | · | $-449.0K | $110M | $10M | $8M | $8M | · | · | · | |
| Net Change in Cash | $2M | $16M | $-52M | $-28M | $-29M | $105M | $-4M | $-4M | $16M | $-2M | $-81M | $74M | |
| Taxes Paid | $28.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | $-42M | $-21M |
Rentabilidad 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -26.3% | · | · | -66.8% | -18.8% | -21.9% | -114.5% | · | -118.8% | · | -51.3% | -33.3% | |
| ROE | -69.4% | · | · | -78.1% | -20.6% | -21.5% | -140.3% | · | -156.6% | · | -54.6% | -96.6% | |
| ROIC | · | · | · | -105.0% | -21.0% | -9.5% | · | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.4 | · | · | 9.2 | 20.1 | 46.6 | 7.5 | · | · | · | 10.9 | 25.3 | |
| Quick Ratio | 7.3 | · | · | 8.7 | 19.3 | 46.0 | 6.6 | · | · | · | 3.9 | 24.8 |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 |
Valoración (TTM) 9
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-46M | $-36M | $-117M | $-88M | $-35M | $-23M | $-16M | $-14M | $-13M | $-6M | $-45M | $-23M | |
| Market Cap | $114M | · | · | $31M | $63M | $233M | $135M | · | $520M | · | $31.92B | $53.45B | |
| P/E | -2.9 | -6.2 | -0.4 | -0.4 | -1.9 | · | · | · | · | · | · | · | |
| P/B | 1.4 | · | · | 0.4 | 0.4 | 1.2 | 14.3 | · | 26.7 | · | 517.2 | 516.4 | |
| P / Tangible Book | 1.4 | 3.9 | · | 1.3 | 0.5 | 1.6 | · | · | · | · | · | · | |
| P / Cash Flow | -1.8 | · | · | -1.1 | -2.2 | -15.3 | -9.8 | · | -34.8 | · | -774.1 | -2530.5 | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | -763.7 | -2527.5 | |
| Earnings Yield | -34.4% | -16.0% | -262.8% | -270.2% | -52.8% | · | · | · | · | · | · | · |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $17M | $17M | $15M | $20M | $14M | $18M | $17M | $10M | $7M | $7M | $8M | $7M | $8M | $7M | $7M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $4M | $4M | $7M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $23M | $21M | $21M | $19M | $25M | $18M | $25M | $21M | $15M | $11M | $10M | $11M | $10M | $11M | $59M | $11M | |
| Operating Income | $-23M | $-21M | · | $-19M | $-25M | $-18M | · | $-21M | $-15M | $-11M | · | $-11M | $-10M | $-11M | · | $-11M | |
| Other Non-op | $862.0K | $1M | $540.0K | $1M | $1M | $1M | $1M | $1M | $869.0K | $574.0K | $712.0K | $849.0K | $775.0K | $338.0K | $304.0K | $127.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-58M | $-10M | |
| Net Income | $-32M | $-39M | $-10M | $-17M | $-11M | $-6M | $-45M | $77M | $-45M | $-24M | $-30M | $-10M | $-66M | $-11M | $-58M | $-10M | |
| EPS (Basic) | $-0.27 | $-0.33 | $-0.10 | $-0.21 | $-0.13 | $-0.08 | $-0.14 | $1.05 | $-0.92 | $-0.65 | · | $-0.33 | $-2.74 | $-0.75 | $-4.09 | $-0.73 | |
| EPS (Diluted) | $-0.27 | $-0.33 | $-0.10 | $-0.21 | $-0.13 | $-0.08 | $1.19 | $-0.28 | $-0.92 | $-0.65 | · | $-0.33 | $-2.74 | $-0.75 | $-4.09 | $-0.73 | |
| Shares (Basic) | 113,631,565 | 112,424,211 | -149,602,653 | 77,156,068 | 77,156,068 | 77,126,763 | -75,669,944 | 51,945,920 | 42,278,411 | 29,989,400 | · | 29,974,400 | 24,006,549 | 14,285,905 | -28,577,249 | 14,265,905 | |
| Shares (Diluted) | 113,631,565 | 112,424,211 | -149,602,653 | 77,156,068 | 77,156,068 | 77,126,763 | -79,202,366 | 55,478,342 | 42,278,411 | 29,989,400 | · | 29,974,400 | 24,006,549 | 14,285,905 | -28,577,249 | 14,265,905 | |
| EBITDA | $-23M | $-21M | · | $-19M | $-25M | $-18M | · | $-21M | $-15M | $-11M | · | $-11M | $-10M | $-11M | · | $-11M |
Balance general 19
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $6M | $23M | $4M | $6M | $8M | $21M | $7M | $26M | $6M | $5M | $4M | $41M | $46M | $56M | $66M | |
| Short-term Investments | $82M | $105M | $111M | $90M | $102M | $116M | $120M | $71M | $58M | $37M | $46M | $56M | $30M | · | $0 | · | |
| Prepaid Expense | $4M | $2M | $2M | $3M | $4M | $3M | $4M | $3M | $4M | $5M | $5M | $3M | $2M | $2M | $3M | $2M | |
| Other Current Assets | $382.0K | $9.0K | $11.0K | $14.0K | $10.0K | $55.0K | $104.0K | $442.0K | $157.0K | $54.0K | $90.0K | $90.0K | $238.0K | $47.0K | $28.0K | $57.0K | |
| Current Assets | $93M | $114M | $136M | $96M | $111M | $128M | $144M | $82M | $87M | $48M | $56M | $63M | $74M | $49M | $60M | $68M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $49M | |
| Other Non-current Assets | $172.0K | $177.0K | $322.0K | $476.0K | $346.0K | $354.0K | $363.0K | $210.0K | $255.0K | $185.0K | $186.0K | $233.0K | $224.0K | $369.0K | $150.0K | $155.0K | |
| Total Assets | $126M | $147M | $169M | $130M | $145M | $161M | $177M | $115M | $120M | $81M | $89M | $96M | $107M | $82M | $93M | $150M | |
| Accounts Payable | $3M | $7M | $4M | $5M | $6M | $3M | $6M | $6M | $2M | $2M | $967.0K | $465.0K | $2M | $3M | $2M | $4M | |
| Current Liabilities | $12M | $13M | $18M | $14M | $14M | $9M | $12M | $12M | $6M | $4M | $4M | $3M | $5M | $5M | $6M | $6M | |
| Capital Leases | $86.0K | $186.0K | $283.0K | $376.0K | $467.0K | $555.0K | $640.0K | $315.0K | $386.0K | $0 | · | $83.0K | $184.0K | $284.0K | $383.0K | $461.0K | |
| Deferred Tax | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $54M | $46M | $32M | $39M | $39M | $47M | $59M | $39M | $129M | $96M | $82M | $5M | $7M | $8M | $9M | $8M | |
| Common Stock | $81.0K | $76.0K | $75.0K | $60.0K | $60.0K | $60.0K | $60.0K | $41.0K | $39.0K | $25.0K | $24.0K | $24.0K | $23.0K | $14.0K | $14.0K | $14.0K | |
| Retained Earnings | $-472M | $-440M | $-401M | $-391M | $-373M | $-362M | $-356M | $-311M | $-388M | $-343M | $-319M | $-234M | $-223M | $-214M | $-203M | $-144M | |
| AOCI | $-114.0K | $-72.0K | $24.0K | $9.0K | $-48.0K | $-18.0K | $26.0K | $102.0K | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $33M | $45M | $81M | $35M | $50M | $59M | $62M | $76M | $-9M | $-15M | $-48M | $91M | $100M | $75M | $84M | $141M | |
| Liabilities + Equity | $126M | $147M | $169M | $130M | $145M | $161M | $177M | $115M | $120M | $81M | $89M | $96M | $107M | $82M | $93M | $150M | |
| Shares Outstanding | 80,891,404 | 75,851,722 | 75,430,033 | 59,881,775 | 59,881,775 | 59,881,775 | 59,789,275 | 41,183,102 | 38,506,614 | 24,813,130 | 24,213,130 | 23,545,130 | 23,043,933 | 13,776,788 | 13,776,788 | 13,756,788 |
Flujo de Efectivo 4
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-23M | $-23M | $-14M | $-14M | $-18M | $-16M | $-19M | $-12M | $-8M | $-9M | $-9M | $-12M | $-8M | $-10M | $-9M | $-5M | |
| Investing Cash Flow | $23M | $6M | $-20M | $12M | $15M | $4M | $-47M | $-13M | $-20M | $10M | $10M | $-25M | · | · | · | · | |
| Financing Cash Flow | · | · | $54M | $0 | $0 | $115.0K | $80M | $5M | $48M | $1.0K | $0 | $0 | · | · | · | · | |
| Net Change in Cash | $651.0K | $-17M | $19M | $-2M | $-3M | $-12M | $14M | $-19M | $20M | $1M | $945.0K | $-37M | $-6M | $-10M | $-9M | $-5M |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -23.3% | -25.3% | · | -14.3% | -8.5% | · | · | 73.1% | -39.5% | · | · | -8.4% | -7.3% | -8.8% | · | -6.4% | |
| ROE | -75.9% | -75.3% | · | -31.3% | -53.6% | · | · | 92.0% | -98.2% | · | · | -8.9% | -7.7% | -9.3% | · | -6.7% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 8.4 | · | 6.7 | 8.1 | 13.9 | · | 6.5 | 14.5 | 11.3 | · | 21.7 | 15.0 | 8.9 | · | 10.8 | |
| Quick Ratio | 7.5 | 8.3 | · | 6.5 | 7.8 | 13.6 | · | 6.3 | 13.9 | 10.1 | · | 20.6 | 14.6 | 8.5 | · | 10.5 |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-99M | $-74M | · | $42M | $14M | $2M | · | $-1M | $-144M | $-110M | · | $-97M | $-96M | $-40M | · | $-39M | |
| Market Cap | $319M | $234M | · | $155M | $162M | $203M | · | $103M | $102M | $51M | · | $32M | $32M | $33M | · | $38M | |
| P/E | -4.2 | -4.1 | · | -3.7 | -1.9 | -1.8 | · | -1.1 | -0.6 | -0.5 | · | -0.3 | -0.3 | -0.8 | · | -1.0 | |
| P/B | 9.7 | 5.2 | · | 4.4 | 3.2 | 3.4 | · | 1.3 | -12.0 | -3.5 | · | 0.4 | 0.3 | 0.4 | · | 0.3 | |
| P / Tangible Book | 9.7 | 5.2 | · | 4.4 | 3.2 | 3.4 | · | 1.3 | · | · | · | 0.4 | 0.3 | 0.4 | · | 0.4 | |
| P / Cash Flow | · | -10.3 | · | · | · | -12.6 | · | · | · | -5.8 | · | · | · | -3.3 | · | · | |
| Earnings Yield | -23.9% | -24.3% | · | -27.0% | -52.0% | -56.9% | · | -87.5% | -175.8% | -217.0% | · | -332.1% | -355.5% | -119.5% | · | -98.9% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Beneficio neto | $-46M | $-36M | $-117M | $-88M | $-35M |
| EPS Diluido | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 7.4 | — | — | 9.2 | 20.1 |
| Ratio Rápido | 7.3 | — | — | 8.7 | 19.3 |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 172 declarantes · $146.2M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 58 (+15 vs trimestre anterior) | 9 (-5 vs trimestre anterior) | 54 (+21 vs trimestre anterior) | 26 (+5 vs trimestre anterior) | +1.6M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BVF INC/IL | $24 795 531 | 6 293 282 | 16,96% | Acciones |
| Defilade Capital Management, L.P. | $13 889 832 | 3 525 338 | 9,50% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $13 463 859 | 3 417 223 | 9,21% | Acciones |
| Ensign Peak Advisors, Inc | $8 278 823 | 2 101 224 | 5,66% | Acciones |
| Catalio Capital Management, LP | $6 678 580 | 1 695 071 | 4,57% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $6 603 582 | 1 675 564 | 4,52% | Acciones |
| STATE STREET CORP | $6 390 558 | 1 621 969 | 4,37% | Acciones |
| Zimmer Partners, LP | $6 290 600 | 1 596 599 | 4,30% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $4 693 277 | 1 191 187 | 3,21% | Acciones |
| AWM Investment Company, Inc. | $4 334 000 | 1 100 000 | 2,97% | Acciones |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $4 094 744 | 1 039 275 | 2,80% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $3 860 065 | 979 712 | 2,64% | Acciones |
| GOLDMAN SACHS GROUP INC | $2 703 782 | 686 239 | 1,85% | Acciones |
| ADAR1 Capital Management, LLC | $2 552 379 | 647 812 | 1,75% | Acciones |
| 22NW, LP | $2 507 274 | 636 364 | 1,72% | Acciones |
| CM Management, LLC | $2 265 500 | 575 000 | 1,55% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $2 245 264 | 569 864 | 1,54% | Acciones |
| Blue Owl Capital Holdings LP | $2 232 045 | 566 509 | 1,53% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 101 458 | 533 365 | 1,44% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 084 114 | 528 963 | 1,43% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $1 837 624 | 466 402 | 1,26% | Acciones |
| Triumph Capital Management | $1 195 565 | 303 443 | 0,82% | Acciones |
| Brevan Howard Capital Management LP | $1 174 645 | 304 707 | 0,80% | Acciones |
| CITADEL ADVISORS LLC | $1 100 836 | 279 400 | 0,75% | Opción de venta |
| JANE STREET GROUP, LLC | $1 095 320 | 278 000 | 0,75% | Opción de venta |
| BIT Capital GmbH | $1 048 040 | 266 000 | 0,72% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $993 794 | 252 232 | 0,68% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $978 302 | 248 300 | 0,67% | Opción de venta |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $974 772 | 247 404 | 0,67% | Acciones |
| CITADEL ADVISORS LLC | $850 934 | 215 973 | 0,58% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $791 546 | 200 900 | 0,54% | Acciones |
| VANGUARD GROUP INC | $680 989 | 450 986 | 0,47% | Acciones |
| LPL Financial LLC | $440 078 | 111 695 | 0,30% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $432 774 | 109 841 | 0,30% | Acciones |
| Maven Securities LTD | $394 000 | 100 000 | 0,27% | Acciones |
| BANK OF AMERICA CORP /DE/ | $370 202 | 93 960 | 0,25% | Acciones |
| RHUMBLINE ADVISERS | $349 112 | 88 609 | 0,24% | Acciones |
| SIMPLEX TRADING, LLC | $349 072 | 88 597 | 0,24% | Acciones |
| Prodigy Asset Management LLC | $341 610 | 86 703 | 0,23% | Acciones |
| Daytona Street Capital LLC | $313 301 | 81 166 | 0,21% | Acciones |
| Rockefeller Capital Management L.P. | $286 304 | 72 666 | 0,20% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $283 361 | 71 919 | 0,19% | Acciones |
| WELLS FARGO & COMPANY/MN | $273 042 | 69 300 | 0,19% | Acciones |
| Shay Capital LLC | $252 160 | 64 000 | 0,17% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $236 006 | 59 900 | 0,16% | Opción de compra |
| PW Nova Financial Services LLC | $228 682 | 58 041 | 0,16% | Acciones |
| Mariner, LLC | $197 149 | 50 041 | 0,13% | Acciones |
| IEQ CAPITAL, LLC | $189 770 | 48 165 | 0,13% | Acciones |
| Bank of New York Mellon Corp | $179 928 | 45 667 | 0,12% | Acciones |
| WOLVERINE TRADING, LLC | $179 324 | 70 600 | 0,12% | Opción de venta |
| MetLife Investment Management, LLC | $161 217 | 40 918 | 0,11% | Acciones |
| BlackRock, Inc. | $160 468 | 40 728 | 0,11% | Acciones |
| Russell Investments Group, Ltd. | $159 499 | 40 482 | 0,11% | Acciones |
| Kera Capital Partners, Inc. | $158 420 | 40 208 | 0,11% | Acciones |
| WOLVERINE TRADING, LLC | $151 318 | 59 574 | 0,10% | Acciones |
| XTX Topco Ltd | $150 930 | 38 307 | 0,10% | Acciones |
| NAVELLIER & ASSOCIATES INC | $141 545 | 35 925 | 0,10% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $139 764 | 35 473 | 0,10% | Acciones |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $133 268 | 34 615 | 0,09% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $131 986 | 33 499 | 0,09% | Acciones |
| MORGAN STANLEY | $131 718 | 33 431 | 0,09% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $129 803 | 32 945 | 0,09% | Acciones |
| CITIGROUP INC | $124 634 | 31 633 | 0,09% | Acciones |
| JPMORGAN CHASE & CO | $123 904 | 31 934 | 0,08% | Acciones |
| MARCO INVESTMENT MANAGEMENT LLC | $119 555 | 30 344 | 0,08% | Acciones |
| Invesco Ltd. | $119 500 | 30 330 | 0,08% | Acciones |
| Retirement Planning Group, LLC | $118 204 | 30 001 | 0,08% | Acciones |
| HOWARD FINANCIAL SERVICES, LTD. | $118 200 | 30 000 | 0,08% | Acciones |
| Cetera Investment Advisers | $113 736 | 28 867 | 0,08% | Acciones |
| KESTRA PRIVATE WEALTH SERVICES, LLC | $108 350 | 27 500 | 0,07% | Acciones |
| SEI INVESTMENTS CO | $106 857 | 27 121 | 0,07% | Acciones |
| Nuveen, LLC | $106 857 | 27 121 | 0,07% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $99 792 | 32 400 | 0,07% | Acciones |
| Vanguard Global Advisers, LLC | $98 248 | 24 936 | 0,07% | Acciones |
| GROUP ONE TRADING LLC | $97 416 | 24 725 | 0,07% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $92 622 | 23 508 | 0,06% | Acciones |
| Creative Planning | $92 428 | 23 459 | 0,06% | Acciones |
| Scientech Research LLC | $90 005 | 22 844 | 0,06% | Acciones |
| JANE STREET GROUP, LLC | $88 173 | 22 379 | 0,06% | Acciones |
| Private Advisor Group, LLC | $85 735 | 21 760 | 0,06% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $84 517 | 21 451 | 0,06% | Acciones |
| Jump Financial, LLC | $83 847 | 21 281 | 0,06% | Acciones |
| INTECH INVESTMENT MANAGEMENT LLC | $76 570 | 19 434 | 0,05% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $75 419 | 19 952 | 0,05% | Acciones |
| Relyea Zuckerberg Hanson LLC | $66 980 | 17 000 | 0,05% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $66 728 | 16 936 | 0,05% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $65 841 | 16 711 | 0,05% | Acciones |
| COMMONWEALTH EQUITY SERVICES, LLC | $65 230 | 16 556 | 0,04% | Acciones |
| Baker Ellis Asset Management LLC | $63 040 | 16 000 | 0,04% | Acciones |
| China Universal Asset Management Co., Ltd. | $63 040 | 16 000 | 0,04% | Acciones |
| VOYA INVESTMENT MANAGEMENT LLC | $62 670 | 15 906 | 0,04% | Acciones |
| CITADEL ADVISORS LLC | $60 282 | 15 300 | 0,04% | Opción de compra |
| BLAIR WILLIAM & CO/IL | $58 875 | 14 943 | 0,04% | Acciones |
| JANE STREET GROUP, LLC | $57 524 | 14 600 | 0,04% | Opción de compra |
| Revolve Wealth Partners, LLC | $55 723 | 14 143 | 0,04% | Acciones |
| Waverly Advisors, LLC | $54 577 | 13 852 | 0,04% | Acciones |
| CAPTRUST FINANCIAL ADVISORS | $53 848 | 13 667 | 0,04% | Acciones |
| NEUBERGER BERMAN GROUP LLC | $51 185 | 12 991 | 0,04% | Acciones |
| Tower Research Capital LLC (TRC) | $51 039 | 12 954 | 0,03% | Acciones |
| SIGNATUREFD, LLC | $50 964 | 12 935 | 0,03% | Acciones |
Informantes de la empresa 27 insiders · 8 directivos · 18 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| David-Alexandre C Gros | Chief Executive Officer | 31 de julio de 2026 F | 168 663 | 0 | 0 | $0 |
| Gregory J. Flesher | Chief Executive Officer | 19 de marzo de 2020 A | 171 556 | 0 | 0 | $0 |
| Paul Sean Little | Chief Financial Officer | 10 de enero de 2025 A | 10 000 | 0 | 0 | $0 |
| Lee Kalowski | Chief Financial Officer | 2 de abril de 2015 S | 52 346 | 0 | 0 | $0 |
| Steven Perrin | President | 31 de julio de 2026 F | 81 215 | 0 | 0 | $0 |
| Bryan E. Smith | General Counsel, Corporate Sec | 10 de enero de 2025 A | — | 0 | 0 | $0 |
| Jon Kuwahara | Senior Vice President of Finance and Administration | 11 de septiembre de 2020 A | 11 250 | 0 | 0 | $0 |
| Gerald E Quirk | General Counsel, Executive VP | 26 de mayo de 2015 A | — | 0 | 0 | $0 |
| Allan Kirk | Consejero | 10 de enero de 2026 M | 3 430 | 0 | 0 | $0 |
| Jan Hillson | Consejero | 10 de enero de 2026 M | 3 430 | 0 | 0 | $0 |
| James A. Robinson Jr. | Consejero | 10 de enero de 2026 M | 3 430 | 0 | 0 | $0 |
| June Lee | Consejero | 10 de enero de 2026 M | 3 430 | 0 | 0 | $0 |
| John S. Mcbride | Consejero | 10 de enero de 2026 M | 3 430 | 0 | 0 | $0 |
| Keith Katkin | Consejero | 10 de enero de 2026 M | 8 575 | 0 | 0 | $0 |
| Walter C Ogier | Consejero | 1 de mayo de 2023 A | — | 0 | 0 | $0 |
| LYONS GARY A | Consejero | 1 de mayo de 2023 A | — | 0 | 0 | $0 |
| CHIMOVITS EREZ | Consejero | 14 de enero de 2020 S | 3 183 314 | 0 | 0 | $0 |
| Cheryl Cohen | Consejero | 11 de julio de 2019 A | — | 0 | 0 | $0 |
| Stephen Buckley Jr. | Consejero | 8 de enero de 2015 A | — | 0 | 0 | $0 |
| Apple Tree Partners II - Annex, L.P. | Consejero | 22 de septiembre de 2014 C | 3 568 438 | 0 | 0 | $0 |
| Seth Loring Harrison | Consejero | 22 de septiembre de 2014 C | 7 912 079 | 0 | 0 | $0 |
| APPLE TREE PARTNERS II LP | Consejero | 22 de septiembre de 2014 C | 4 218 641 | 0 | 0 | $0 |
| BARBERICH TIMOTHY J | Consejero | 22 de septiembre de 2014 C | 121 077 | 0 | 0 | $0 |
| Satter Muneer A | Propietario del 10% | 22 de septiembre de 2014 C | 1 771 688 | 0 | 0 | $0 |
| Catherine C. Turkel | — | 19 de marzo de 2020 A | 98 199 | 0 | 0 | $0 |
| Jodie Pope Morrison | — | 30 de junio de 2017 A | — | 0 | 0 | $0 |
| Christine Ocampo | — | 24 de mayo de 2017 A | 21 590 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| OrbiMed Israel BioFund GP Limited Partnership, OrbiMed Israel GP Ltd. ×9 presentaciones | 5 de enero de 2021 | — | Presentación inicial | — | SEC |
| Novartis Bioventures Ltd., Novartis AG ×3 presentaciones | 5 de abril de 2019 | — | Presentación inicial | — | SEC |
| Apple Tree Partners II, L.P., Apple Tree Ventures II, L.P., Apple Tree Partners II - Annex, L.P., Apple Tree Ventures II - Annex, LLC, Apple Tree Partners IV, L.P., ATP III GP, Ltd., Seth L. Harrison ×4 presentaciones | 15 de mayo de 2018 | — | Presentación inicial | — | SEC |
| Novartis Bioventures Ltd. (2), Novartis AG (2) | 16 de mayo de 2017 | — | Presentación inicial | — | SEC |
| Otic Pharma, Ltd. | 5 de enero de 2017 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 17 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| RSSL · Global X Funds | 0,01% | 32 354 NS | 30 de abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 3 517 NS | 31 de mayo de 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 39 630 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 165 567 NS | 30 de abril de 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 2 750 NS | 31 de mayo de 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 2 782 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 70 NS | 31 de mayo de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 17 419 NS | 30 de abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| IWO · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWM · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWC · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 de julio de 2026 | Diario |